Phylogenetic background and virulence genotype of ciprofloxacin-susceptible and ciprofloxacin- resistant escherichia coli strains of human and avian origin

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1209-1217

  Graziani, Caterina ^a   Luzzi, Ida ^b   Corrò, Michela ^e   Tomei, Fiorella ^c   Parisi, Gabriella ^d   Giufrè, Maria ^b   Morabito, Stefano ^a   Caprioli, Alfredo ^a   Cerquetti, Marina ^b  

^a Departments of Veterinary Public Health and Food Safety

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c BIOS Laboratorio

^d Circonvallazione Gianicolense   (Romania)

^e ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AVIAN COLIBACILLOSIS; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENOTYPE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; HUMANS; PHYLOGENY; POULTRY; POULTRY DISEASES; VIRULENCE;

EID: 65649129638     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597423     Document Type: Article

References (47)

1. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E. coli." J Lab Clin Med 2002; 139:155-62.
2. Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003; 17:261-78.
3. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 2003; 5:449-56.
4. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123-40.
5. Barnes HJ, Vaillancourt JP, Goss WB. Colibacillosis. In: Saif YM, Barnes HJ, Glisson JR, FRadly AM, McDougald LR, Swayne DE, eds. Diseases of poultry. 11th ed. Ames, IA: Ames University Press, 2003:631-52.
6. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Nolan LK. Characterizing the APEC pathotype. Vet Res 2005; 36:241-56.
7. Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Vet Res 1999; 30:299-316.
8. Zhao S, Maurer JJ, Hubert S, et al.Antimicrobial susceptibility and molecular characterization of avian pathogenic Escherichia coli isolates. Vet Microbiol 2005; 107:215-24.
9. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005; 295:383-404.
10. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 2005; 151: 2097-110.
11. Ron EZ. Host specificity of septicemic Escherichia coli: human and avian pathogens. Curr Opin Microbiol 2006; 9:28-32.
12. Moulin-Schouleur M, Répérant M, Laurent S, et al.Extraintestinal pathogenic Escherichia coli strains of avian and human origin: link between phylogenetic relationships and common virulence patterns. J Clin Microbiol 2007; 45:3366-76.
13. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003; 17:243-59.
14. Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B. Cotrimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Int J Antimicrob Agents 2005; 26:75-7.
15. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135:41-50.
16. Collignon P, Angulo FJ. Fluoroquinolone-resistant Escherichia coli: food for thought. J Infect Dis 2006; 194:8-10.
17. Johnson JR, Kuskowski MA, Menard M, Gajewski A, Xercavins M, Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis 2006; 194:71-8.
18. Lautenbach E, Fishman NO, Metlay JP, et al.Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis 2006; 194:79-85.
19. Sabaté M, Prats G, Moreno E, Ballesté E, Blanch AR, Andreu A. Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater. Res Microbiol 2008; 159: 288-93.
20. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. CLSI/NCCLS document M100-S16. Wayne, PA: CLSI, 2006.
21. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the E. coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
22. Karch H, Böhm H, Schmidt H, Gunzer F, Aleksic S, Heesemann J. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol 1993; 31: 1200-05.
23. Schmidt H, Knop C, Franke S, Aleksic S, Heesemann J, Karch H. Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol 1995; 33:701-5.
24. Kadhum HJ, Ball HJ, Oswald E, Rowe MT. Characteristics of cytotoxic necrotizing factor and cytolethal distending toxin producing Escherichia coli strains isolated from meat samples in Northen Ireland. Food Microbiol 2006; 23:491-97.
25. Toth I, Herault F, Beutin L, Oswald E. Production of cytolethal distending toxins by human and animal pathogenic Escherichia coli strains: establishment of the existence of a new cdt variant (type IV). J Clin Microbiol 2003; 41:4285-91.
26. Chang HH, Sheu SY, Lo SJ. Expression of foreign antigens on the surface of E. coli by fusion to the outer membrane protein TRAT. J Biomed Sci 1999; 6:64-70.
27. Johnson JR, Stell A L. Extended virulence genotypes of. E. coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181:261-72.
28. Russo TA, McFadden CD, Carlino-MacDonald UB, Beanan JM, Barnard TJ, Johnson JR. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 2002; 70:7156-60.
29. Nolan LK, Horne SM, Giddings CW, et al.Resistance to serum complement, iss, and virulence of avian Escherichia coli. Vet Res Commun 2003; 27:101-10.
30. Herrero M, de lorenzo V, Neilands JB. Nucleotide sequence of the iucD gene of the pColV-K30 aerobactin operon and topology of its product studied with phoA and lacZ gene fusions. J Bacteriol 1988; 170:56-64.
31. Dozois CM, Dho-Moulin M, Brèe A, Fairbrother JM, Desaultels C, Curtiss R 3rd. Relationship between the Tsh autotransporter and pathogenicity of avian E. coli and localization and analysis of the tsh genetic region. Infect Immun 2000; 68:4145-54.
32. Morabito S, Karch H, Schmidt H, et al.Molecular characterization of verocytotoxin-producing Escherichia coli of serogroup O111 from different countries. J Med Microbiol 1999; 48:891-6.
33. Hunter SB, Vauterin P, Lambert-Fair MA, et al.Establishment of a universal size standard strain for use with the PulseNet standardized pulsedfield gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005; 43:1045-50.
34. Picard B, Garcia JS, Gouriou S, et al.The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67:546-53.
35. Maynard C, Bekal S, Sanschagrin F, et al. Heterogeneity among virulence and antimicrobial resistance gene profiles of extraintestinal Escherichia coli isolates of animal and human origin. J Clin Microbiol 2004; 42:5444-52.
36. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 2008; 46:480-7.
37. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 2003; 188:759-68.
38. Johnson JR, Kuskowski MA, O'Bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2005; 49:26-31.
39. Moreno E, Prats G, Sabaté M, Pérez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 2006; 57:204-11.
40. Johnson JR, Sannes MR, Croy C, et al.Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis 2007; 13:838-46.
41. Vila J, Simon K, Ruiz J, Horcajada JP, et al.Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002; 186:1039-42.
42. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother 2005; 49: 4739-44.
43. Drews SJ, Poutanen SM, Mazzulli T, et al.Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 2005; 43:4218-20.
44. Horcajada JP, Soto S, Gajewski A, et al.Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43:2962-4.
45. Soto SM, Jimenez de Anta MT, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOSdependent or-independent pathways, respectively. Antimicrob Agents Chemother 2006; 50:649-53.
46. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25: H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46:2605-12.
47. Fàbrega A, Sánchez-Céspedes J, Soto S, Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents 2008; 31:307-15.